Group One Trading’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.95M | Sell |
|
|||||
|
2025
Q1 | $7.35M | Sell |
|
|||||
|
2024
Q4 | $8.32M | Buy |
|
|||||
|
2024
Q3 | $4.09M | Buy |
|
|||||
|
2024
Q2 | $2.93M | Buy |
|
|||||
|
2024
Q1 | $1.77M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $714K | Sell |
|
|||||
|
2023
Q2 | $5.05M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $1.8M | Sell |
|
|||||
|
2022
Q3 | $3.3M | Sell |
|
|||||
|
2022
Q2 | $5.2M | Buy |
|
|||||
|
2022
Q1 | $3.24M | Sell |
|
|||||
|
2021
Q4 | $4.71M | Buy |
|
|||||
|
2021
Q3 | $3.38M | Sell |
|
|||||
|
2021
Q2 | $4.28M | Sell |
|
|||||
|
2021
Q1 | $6.6M | Sell |
|
|||||
|
2020
Q4 | $12.5M | Buy |
|
|||||
|
2020
Q3 | $6.28M | Buy |
|
|||||
|
2020
Q2 | – | Hold |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $743K | Sell |
|
|||||
|
2019
Q3 | $4.58M | Buy |
|
|||||
|
2019
Q2 | $843K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $2.88M | Sell |
|
|||||
|
2018
Q3 | $3.61M | Buy |
|
|||||
|
2018
Q2 | $2.73M | Buy |
|
|||||
|
2018
Q1 | $1.41M | Sell |
|
|||||
|
2017
Q4 | $10.5M | Buy |
|
|||||
|
2017
Q3 | $1.45M | Buy |
|
|||||
|
2017
Q2 | $244K | Sell |
|
|||||
|
2017
Q1 | $2.07M | Sell |
|
|||||
|
2016
Q4 | $8.38M | Sell |
|
|||||
|
2016
Q3 | $9.68M | Buy |
|
|||||
|
2016
Q2 | $4.01M | Sell |
|
|||||
|
2016
Q1 | $4.41M | Buy |
|
|||||
|
2015
Q4 | $4.02M | Sell |
|
|||||
|
2015
Q3 | $6.8M | Buy |
|
|||||
|
2015
Q2 | $4.93M | Sell |
|
|||||
|
2015
Q1 | $6.01M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $348K | Sell |
|
|||||
|
2014
Q2 | $2.92M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $804K | Sell |
|
|||||
|
2013
Q3 | $1.08M | Buy |
|
|||||
|
2013
Q2 | – | Hold |
|